Phenytoin
NDC 54868-2038
Product Information
Phenytoin is a ANDA-approved product labeled by Physicians Total Care, Inc.. Phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). It is supplied as a product. This product entry covers the primary NDC 54868-2038 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 54868-2038?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PHENYTOIN (UNII: 6158TKW0C5)
- PHENYTOIN (UNII: 6158TKW0C5) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)
- GLYCERIN (UNII: PDC6A3C0OX)
- CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- RAW SUGAR (UNII: 8M707QY5GH)
- POLYSORBATE 40 (UNII: STI11B5A2X)
- WATER (UNII: 059QF0KO0R)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- ALCOHOL (UNII: 3K9958V90M)
- VANILLIN (UNII: CHI530446X)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1313112 - phenytoin 125 MG in 5 mL Oral Suspension
- RxCUI: 1313112 - phenytoin 25 MG/ML Oral Suspension
- RxCUI: 1313112 - DPH 25 MG/ML Oral Suspension
- RxCUI: 1313112 - phenytoin 100 MG per 4 ML Oral Suspension
- RxCUI: 1313112 - phenytoin 125 MG per 5 ML Oral Suspension
* Please review the full disclaimer at the bottom of this page.